A long-acting shot Pfizer got through a buyout of Metsera appeared “slightly inferior” to Lilly’s market-leading Zepbound in ...
Pfizer's long-acting GLP-1 weight loss candidate could set the stage for a stock rally.
Hosted on MSN
Pfizer scientist subpoenaed over claims COVID vax testing was ‘deliberately’ slowed before 2020 election
WASHINGTON — A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that senior executives at the pharma giant colluded to “deliberately slow down” clinical tests of its ...
(AP) – A real-world test of Pfizer’s COVID-19 vaccine in more than half a million people confirms that it’s very effective at preventing serious illness or death, even after one dose. Wednesday’s ...
Pfizer (PFE) chairman and CEO Albert Bourla joins Julie Hyman on Market Domination to talk more about the pharmaceutical ...
Pfizer Inc. (NYSE: PFE) helped boost the Dow Jones Industrial Average (DJIA) the day after delivering a double beat in its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results